Type 1 Diabetes and LADA

Prepared and reviewed by the PrepElephant Academic Review Team

First published 14 Oct 2026 · Spot an error?

Reference basis: Williams Textbook of Endocrinology; Harrison's Principles of Internal Medicine

On this page

Direct answer
What you must remember
Separating type 1, LADA and type 2 at the bedside
High-yield viva angles
Frequently asked questions
Related topics

Direct answer

Type 1 diabetes is an autoimmune disease in which T cells destroy pancreatic beta cells, leaving the patient absolutely insulin deficient and prone to ketoacidosis. Latent autoimmune diabetes in adults, or LADA, is a slower form that presents in adulthood, initially looks like type 2 diabetes, and is confirmed by GAD65 antibodies.

What you must remember

Mechanism: progressive T cell-mediated destruction of beta cells, with HLA DR3 and DR4 genotypes carrying the strongest genetic risk.
Autoantibodies: GAD65, IA-2, ZnT8 and insulin autoantibodies mark autoimmunity and help predict progression.
Honeymoon phase: a temporary remission after diagnosis, with falling insulin needs while residual beta cell function lasts.
C-peptide: low or undetectable C-peptide reflects absolute insulin deficiency and separates type 1 from type 2 diabetes.
LADA: adult onset, usually after age 30, GAD65 positive, initially not insulin requiring and progressing to insulin dependence over months to years.
Associations: Hashimoto thyroiditis, Graves disease, Addison disease, coeliac disease and vitiligo, which link to polyglandular autoimmunity.
Treatment: insulin is the durable therapy in both forms, while oral agents are less effective as the disease advances.

Separating type 1, LADA and type 2 at the bedside

Students lose marks by treating every adult with diabetes as type 2 without checking antibodies. The table compares the three presentations on the features examiners test most often.

Feature	Type 1 diabetes	LADA	Type 2 diabetes
Typical onset	Childhood to young adult	Adults, usually after age 30	Adults, increasingly younger
Body habitus	Often lean	Often lean or normal weight	Often obese
Antibodies	GAD65, IA-2 and ZnT8 frequently positive	GAD65 positive	Usually negative
C-peptide	Low or absent early	Falls over time	Often preserved initially
Insulin need	Immediate, often with ketosis	Delayed, over months to years	Often much later

A lean adult with positive GAD65 antibodies who is not yet on insulin has LADA rather than early type 2 diabetes, and needs monitoring for progression. Antibody status and serial C-peptide values guide the timing of insulin. Because beta cell reserve falls over time, these values are rechecked at follow-up rather than read once at diagnosis.

High-yield viva angles

Examiners test the age cut-off and the true meaning of remission.

Trap: Assuming honeymoon remission means the disease has resolved. Correct: Beta cell function declines afterwards, so insulin dosing must be reviewed and insulin is never safely stopped.
Trap: Using a sulfonylurea as long-term therapy in LADA on type 2 reasoning. Correct: LADA progresses to insulin dependence, so insulin is the durable treatment.
Trap: Ruling out autoimmune diabetes because the patient is an adult. Correct: LADA is an adult form, so GAD65 antibodies must be measured in lean adults with diabetes.

Frequently asked questions

Which antibody confirms latent autoimmune diabetes in adults?

GAD65 antibody is the antibody most commonly used to confirm latent autoimmune diabetes in adults. Its positivity in an adult who is not yet insulin dependent separates LADA from type 2 diabetes.

What is the honeymoon phase in type 1 diabetes?

The honeymoon phase is a temporary period after diagnosis when residual beta cell function lowers the insulin requirement. It lasts a variable period, often months, and insulin needs rise again as beta cell function declines, so it is not a cure.

Why does LADA respond poorly to oral antidiabetic drugs over time?

Autoimmune destruction of beta cells in LADA progresses, so the residual insulin secretion that oral agents depend on falls. Insulin therapy then becomes necessary, because sulfonylureas and other oral drugs lose effect as the disease advances.

Which antibodies are measured in new-onset type 1 diabetes?

GAD65, IA-2, ZnT8 and insulin autoantibodies are measured in new-onset type 1 diabetes, with islet cell antibodies used in some settings. Positivity confirms autoimmunity, and the number of positive antibodies helps predict progression in at-risk relatives.